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1. Introduction 
3a,7ar,l2o-Trihydroxy-SP-cholestanoic acid 
(THCA) is considered to be a precursor for cholic 
acid formation [l]. 3a,7a,l2cr,24-Tetrahydroxy-5/3- 
cholestanoic acid is a probable intermediate in the 
reaction [2-4]. 24-Hydroxylation of THCA has been 
shown to be catalyzed by the mitochondrial fraction 
of rat liver in combination with the 100 000 X g 
supematant fluid [4,5]. The microsomal fraction in 
combination with the 100 000 X g supernatant and 
ATP also catalyzes 24hydroxylation [4] and the 
reaction was shown to be due to the combined action 
of a desaturase and a hydratase [4]. The final thiol- 
ytic cleavage of the side chain in cholic acid forma- 
tion [6] has been shown to be catalyzed by the mito- 
chondrial fraction [3 5 ;I], the soluble fraction [3,5], 
or by a combination of the microsomal fraction and 
the 100 000 X g supernatant [7]. 
The over-all formation of cholic acid from THCA 
in the mitochondrial fraction is dependent on the 
presence of ATP, coenzyme A, NAD and Mg2+ in the 
reaction medium [5 ;I]. It thus appears that this reac- 
tion has certain features in common with the Poxida- 
tion of fatty acids. 
Recently, a fatty acid oxidizing system different 
from the one present in the mitochondria has been 
identified in the peroxisomal fraction of both rat 
[8,9] and human [lo] liver. On the basis of these 
findings the subcellular localization of cholic acid 
formation has been further investigated. This work 
shows that the peroxisomal fraction of rat liver is able 
to catalyze the conversion of THCA into cholic acid. 
2. Materials and methods 
3a,7~~,12c~-Trihydroxy-5/3-[7~-~H]cholestanoic 
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acid (0.2 mCi/flmol) was prepared as in [4]. The 
compound was purified on high pressure liquid chro- 
matography (HPLC) (see below) immediately before 
use. The compound was a mixture of the two C-25 
stereoisomers, but since both forms are converted 
equally well into cholic acid by rat liver subcellular 
fractions [7] no attempt was made to separate the 
25R from the 25s form. 3a,7a,l2a-Trihydroxy-S/3- 
cholestanoic acid was isolated from a sample of bile 
of a Caiman species [4]. 3a,7ct,12a,24-Tetrahydroxy- 
5/3-[7P-3H]cholestanoic acid (0.2 mCi/mol) was pre- 
pared biosynthetically as in [7]. 14C-Labeled cholic 
acid used as a reference substance was from the 
Radiochemical Centre (Amersham). Percoll was the 
product of Pharmacia (Uppsala). NAD, ATP and 
coenzyme A were from Sigma (St Louis, MO). All 
solvents were analytical or HPLC grade. Other chemi- 
cals were standard commercial high purity materials. 
Male Wistar rats (-200 g body wt) and given a 
commercial pellet diet were used. 
2 .l . Preparation of liver subcellular fractions 
From a 10% liver homogenate in 0.25 M sucrose, 
15 mM Hepes buffer (pH 7.4), 1 mM EGTA, a post- 
nuclear supematant was prepared by centrifugation 
at 2500 rev./min for 10 min in the HB 4 rotor in a 
Sorvall RC2-B centrifuge. The pellet was rehomoge- 
nized and the suspension recentrifuged. The com- 
bined supematants were centrifuged at 7500 rev./min 
(5200 X g,) for 10 min in the SS 34 rotor. The 
resulting pellet was washed 2 times and finally resus- 
pended in the homogenization buffer. This fraction 
is called the heavy mitochondrial fraction. The 
5200 X g supematant was centrifuged at 16 200 
rev./min (24 200 X g,) for 10 min in the SS 34 
rotor. The pellet was washed twice, resuspended in 
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the homogenization buffer and termed light mito- solution (Dilusolve, Packard Instruments) 4 ml, was 
chondrial fraction. The supernatant was centrifuged added and the fractions were counted in a Packard 
at 29 000 rev./min for 1 h in the 30 rotor of a Tricarb liquid scintillation spectrometer. To locate 
Beckman ultracentrifuge. The resulting microsomal the cholic acid formed, 14C-labeled cholic acid was 
pellet was resuspended in the buffer. The supernatant used as a reference. Recovery of radioactivity from 
was used as cytosolic fraction. the HPLC column was essentially complete. 
2.2. Preparation of peroxisomes 
A peroxisomal-enriched fraction was separated on 
a Percoll gradient in a vertical rotor (Beckman VT1 50) 
by minor modifications of the procedure in [ 1 I]. The 
subcellular liver fraction L layered on top of the gra- 
dient was obtained by centrifugation of the post- 
nuclear supernatant above at 16 300 rev./min 
(24 500 X g,,) for 10 min in the Sorvall SS 34 rotor. 
Fractions of 2.5 ml were collected from the bottom 
of the gradient. 
3. Results 
The following marker enzymes were measured in 
the collected fractions: cytochrome c oxidase [ 121; 
monoamine oxidase [ 13 1; rotenone-insensitive 
NADPH-cytochrome c reductase [ 141; urate oxidase 
[ 151; catalase [ 161; /3-IV-acetyl-D-glucosaminidase 
[ 171. Protein was determined by the Lowry method 
[W 
2.3. Incubation, extraction and chromatographic 
procedures 
In consonance with [3,5,7 ] it was confirmed that 
both the microsomal fraction fortified with the 
100 000 X g supernatant and a conventionally pre- 
pared mitochondrial fraction of rat liver (9200 X gav 
for 10 min) catalyzed the formation of cholic acid 
from THCA in the presence of NAD, CoA, ATP and 
Mg2+. By further fractionation of the mitochondria 
into a heavy (a 5200 X g, pellet) and a light 
(24 000 X g,, pellet) fraction it was observed that the 
latter was the most active. A typical HPLC profile of 
the incubation extract of such a fraction is shown in 
fig.1. The main product peak had the same retention 
time as cholic acid. The identity of the product was 
verified by gas chromatography-mass spectrometry 
[ 191. After conversion of the material into methyl 
ester trimethylsilyl derivative, peaks were observed in 
the mass spectrum at m/e 638 (M), m/e 623 (M-l 5), 
Under standard conditions the incubation mixture 
contained the following in 1.5 ml 0.1 M Tris-HCI 
buffer (pH 8.5): 1.5 nmol NAD, 3.75 nmol ATP, 
1.3 nmol coenzyme A, 15 nmol MgC& and subcellu- 
lar fraction corresponding to l-2 mg protein. The 
reaction was started by the addition of 20 ng unla- 
beled THCA together with -100 000 cpm of labeled 
THCA in a total of <15 nl ethanol, and continued for 
60 min at 37’C. The reaction was terminated by the 
addition of 30 ~16 N KOH. After 30 min of hydroly- 
sis at 5O’C the mixture was acidified by HCl and 
extracted twice with ethylacetate. The ethylacetate 
was washed twice with HaO, evaporated under nitro- 
gen and the residue was redissolved in 100 nl metha- 
nol. Omission of the hydrolysis step resulted in the 
loss of an appreciable proportion of the radioactivity, 
especially after incubation with the microsomal frac- 
tion. Aliquotes of the extract were injected into a 
Spectra-Physics HPLC instrument fitted with a 
Zorbax ODS column (4.6 X 250 mm) and eluted 
with a solvent consisting of 10 mM acetate buffer 
(pH 4.37), 18.5% in methanol. The flow rate was 
1 ml/min and 1 ml fractions were collected. Counting 
I I I I I I 1 
10 20 30 
Retention time (min 1 
Fig.1. HPLC on Zorbax ODS of the ethylacetate xtract of 
incubation of THCA with the light mitochondrial fraction of 
rat liver. The incubation conditions as well as extraction and 
chromatography are described in section 2. 
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and m/e 368 (M-3 X 90). In addition to the product 
with the same retention time as cholic acid one 
smaller product peak slightly more polar than the 
substrate was seen. This material was not identified. 
The retention time on HPLC was different from that 
of 3cu,7a?,l2a,24-tetrahydroxy-S@cholestanoic acid. 
Also some material less polar than the product was 
observed. 
When the specific activity of the individual frac- 
tions for cholic acid formation were compared, by far 
the most active was the light mitochondrial fraction 
(table 1). This finding suggested that this activity was 
not truly localized to the mitochondria but to some 
contaminating subcellular particles. After separation 
of the light mitochondrial fraction (24 500 X gav 
pellet) on a Percoll gradient i  was found that the 
activity for cholic acid formation from THCA in the 
different fractions followed the same pattern as the 
marker enzyme for peroxisomes, i.e., urate oxidase 
(t&.2), and also catalase (not shown). The peroxi- 
somal fraction was to some extent contaminated by 
microsomes as detected by the NADPH-cytochrome c 
reductase activity. The data in table 1 exclude the 
possibility that the cholic acid formation in this frac- 
tion is catalyzed by the cont~inating microsomes. 
The lysosomes as detected by /.I-N-acetyl-D-glucosami- 
nidase were well separated from the peroxisomes 
(not shown). 
In order to obtain a reasonable percentage trans- 
formation of labeled THCA throughout he gradient 
only 1 pg substrate was used in the particular experi- 
ment shown in fig.2. When near saturating level of 
substrate was used (20 pg) the specific activity in 
the fraction containing the highest urate oxidase 
activity (fraction 11) was -750 ng cholic acid 
Table 1 
Formation of chohc acid from 3o,7a,l2c&rihydroxy- 
cholestanoic acid by rat liver subcellular fractions 
(ng .mg-‘.h-‘) ~ 
Fraction Formation of cholic acid 
Heavy mitochondria 134 
Light mitochondria 541 
Peroxisomesa 7.52 
Microsomesb IS7 
Cytosol 18 
a Corresponding to fraction no. 1 I from the Percoll gradient 
(section 2) 
b In the absence of the 100 000 X g supernatant fraction 
The incubations were performed as in section 2 
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Fig.2. Profiles of protein and enzyme activities from a self- 
generated Percoll gradient after centrifugation in a vertical 
rotor. A subcellular fraction L from rat liver was centrifuged 
in the VTi SO rotor as in section 2. The gradient was frac- 
tioned into 2.5 ml fractions. Protein and enzyme activities 
are expressed as percentage of the amount in the whole gra- 
dient. (A) Protein; (B) cytochrome c oxidase; (Cc) monoamine 
oxidase; (Df rotenone-insensitive ~ADPH-cytochrome c 
reductase; (E) urate oxidase; (F) cholic acid formation. 
formed . mg-’ . h-‘,i.e., an increase of -50% com- 
pared to the light mitochondrial fraction (table 1). 
The formation of cholic acid from THCA by the 
peroxisomal fraction required the presence of NAD, 
CoA, ATP and Mg** (table 2). 
4. Discussion 
Several studies [3,5,7] have shown that the mito- 
chondrial fraction of rat liver catalyzes the formation 
of cholic acid from THCA. In these studies the mito- 
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Table 2 Acknowledgements 
Cofactor requirement for the conversion of 3a,7a,l2o- 
trihydroxydif-cholestanoic acid to cholic acid by rat liver 
peroxisomal fraction (%) 
Alterations Conversion 
Complete systema 22.6 
h4iUU8 NAD 2.4 
Minus ATP 0.6 
Minus CoA 0.6 
Minus MgCl, 0.9 
Minus all cofactors n.d. 
a The peroxisomal fraction corresponding to 0.63 mg protein 
was incubated with 1 pg THCA as in section 2; n.d., not 
detectable 
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